
Cancer pain is a serious public health issue and more effective treatments are zzso This study evaluates the zzso activity of zzso a highly selective sodium channel zzso This randomized, zzso parallel design study of subcutaneous zzso in patients with moderate or severe zzso cancer pain zzso despite best available treatment, involved 22 centers across zzso The design called for zzso administered zzso over Days zzso with a period of observation to Day 15 or zzso All patients could enroll into an zzso extension efficacy and safety zzso The primary zzso was the proportion of zzso zzso in each treatment zzso zzso patients were randomized, and results on 77 were available for zzso There was a zzso significant trend toward more zzso in the active treatment arm based on the primary zzso zzso intensity zzso However, analysis of secondary zzso and an exploratory post hoc analysis, suggested there may be a robust zzso effect if a composite zzso is used, including either fall in pain level, or fall in zzso dose, plus improvement in quality of zzso Most patients described transient zzso zzso or other mild sensory phenomena within about an hour of each zzso zzso and other zzso were generally mild, but one patient experienced a serious, adverse event, zzso and gait zzso This trial suggests zzso may potentially relieve moderate to zzso zzso cancer pain in a large proportion of patients, and often for prolonged periods following treatment, but further study is warranted using a composite primary zzso 

